Displaying 1 - 50 of 179 results
Released Company Title Industry Topic
03 Jun 2024
18:02 CEST
BERGENBIO BerGenBio ASA - Registration of reverse share split 20103010 Biotechnology Total number of voting rights and capital
30 May 2024
07:00 CEST
BERGENBIO BerGenBio ASA - Ex. reverse share split and change of ISIN today 20103010 Biotechnology Ex Date
29 May 2024
07:00 CEST
BERGENBIO BerGenBio First Quarter Results 2024: Advancing to the Next Stage of Development 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
28 May 2024
15:11 CEST
BERGENBIO BerGenBio Announces NCI Clinical Collaboration with UT Health San Antonio and Sobi® 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
28 May 2024
14:00 CEST
BERGENBIO BerGenBio ASA - Key information relating to the reverse share split and change of ISIN 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
28 May 2024
10:08 CEST
BERGENBIO BerGenBio ASA: New share capital registered 20103010 Biotechnology Total number of voting rights and capital
23 May 2024
17:15 CEST
BERGENBIO BerGenBio ASA - Minutes from the annual general meeting 2024 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
22 May 2024
07:00 CEST
BERGENBIO BerGenBio ASA: Invitation to first quarter 2024 results webcast 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
30 Apr 2024
14:00 CEST
BERGENBIO BerGenBio ASA: Notice of Annual General Meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
30 Apr 2024
13:00 CEST
BERGENBIO BERGENBIO ASA: BOARD APPROVAL OF 2023 ANNUAL FINANCIAL STATEMENT AND ANNUAL REPORT 2023 20103010 Biotechnology Annual financial and audit Reports
25 Apr 2024
12:55 CEST
BERGENBIO BerGenBio ASA: New share capital registered 20103010 Biotechnology Total number of voting rights and capital
17 Apr 2024
17:10 CEST
BERGENBIO BerGenBio ASA: Resolution to increase the share capital for settlement of underwriting commission 20103010 Biotechnology Total number of voting rights and capital
17 Apr 2024
09:42 CEST
BERGENBIO BerGenBio - Disclosure of shareholding 20103010 Biotechnology Major shareholding notifications
17 Apr 2024
08:16 CEST
BERGENBIO BerGenBio - Disclosure of large shareholding 20103010 Biotechnology Major shareholding notifications
16 Apr 2024
14:15 CEST
BERGENBIO BerGenBio ASA: Final results for the last exercise period for warrants issued in connection with rights issue 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
15 Apr 2024
10:58 CEST
BERGENBIO BerGenBio ASA: Mandatory notification of trade by primary insiders and close associates 20103010 Biotechnology Mandatory notification of trade primary insiders
15 Apr 2024
07:00 CEST
BERGENBIO BerGenBio ASA: Siste dag av den siste utøvelsesperioden for de frittstående tegningsrettene utstedt i forbindelse med fortrinnsrettsemisjonen 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
15 Apr 2024
07:00 CEST
BERGENBIO BerGenBio ASA: Last day of the last exercise period for warrants issued in connection with rights issue 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
08 Apr 2024
07:15 CEST
BERGENBIO BerGenBio ASA: Last day of trading in warrants 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
08 Apr 2024
07:00 CEST
BERGENBIO Mandatory notification of trade by related party to Primary Insiders 20103010 Biotechnology Mandatory notification of trade primary insiders
03 Apr 2024
13:22 CEST
BERGENBIO BerGenBio ASA: Information about the last exercise period for Warrants issued in connection with rights issue 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
02 Apr 2024
08:50 CEST
BERGENBIO BerGenBio ASA: Start av den siste utøvelsesperioden for de frittstående tegningsrettene utstedt i forbindelse med fortrinnsrettsemisjonen 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
02 Apr 2024
08:50 CEST
BERGENBIO BerGenBio ASA: Commencement of the last exercise period for warrants issued in connection with rights issue 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
02 Apr 2024
07:55 CEST
BERGENBIO BerGenBio ASA secures underwriting of NOK 118 million gross proceeds representing minimum 80% exercise of the remaining Warrants, providing funding into 2H 2025 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
27 Mar 2024
15:59 CET
BERGENBIO BerGenBio ASA: Exercise price in the last exercise period for warrants issued in connection with rights issue 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
20 Mar 2024
17:15 CET
BERGENBIO BerGenBio Announces Initiation of Phase 2a in First Line Non-Small Lung Cancer Patients with a STK11 mutation 20103010 Biotechnology Inside information
04 Mar 2024
07:00 CET
BERGENBIO BerGenBio to Participate in Carnegie Nordic Healthcare Seminar 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
19 Feb 2024
17:58 CET
BERGENBIO BerGenBio ASA - Approval and publication of a prospectus supplement 20103010 Biotechnology Prospectus / admission document
14 Feb 2024
07:00 CET
BERGENBIO BerGenBio's Fourth Quarter 2023 Results: Focused Strategy Gathers Momentum 20103010 Biotechnology Inside information
14 Feb 2024
07:00 CET
BERGENBIO BerGenBios resultater for fjerde kvartal 2023: Fokusert strategi gir momentum 20103010 Biotechnology Innsideinformasjon
07 Feb 2024
12:00 CET
BERGENBIO BerGenBio Announces New Preclinical Data Indicating Broadened Potential for Bemcentinib to Treat Severe Respiratory Infections 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
06 Feb 2024
07:00 CET
BERGENBIO BerGenBio ASA: Invitation to fourth quarter 2023 results webcast 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
05 Jan 2024
17:14 CET
BERGENBIO BerGenBio ASA – Disclosure of large shareholding 20103010 Biotechnology Major shareholding notifications
15 Dec 2023
16:48 CET
BERGENBIO BerGenBio announces closure of EU-SolidAct bemcentinib study arm in hospitalized COVID-19 patients 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
12 Dec 2023
07:00 CET
BERGENBIO BerGenBio to Present at DNB Nordic Healthcare Conference 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
11 Dec 2023
07:00 CET
BERGENBIO BerGenBio Announces Final Bemcentinib Phase 2 Data in AML and MDS Presented at the 2023 ASH Meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
08 Dec 2023
18:10 CET
BERGENBIO BerGenBio ASA: Grant of share options 20103010 Biotechnology Mandatory notification of trade primary insiders
08 Dec 2023
08:33 CET
BERGENBIO BerGenBio ASA - New share capital registered 20103010 Biotechnology Total number of voting rights and capital
07 Dec 2023
14:05 CET
BERGENBIO BerGenBio ASA: Approval and publication of prospectus 20103010 Biotechnology Prospectus / admission document
07 Dec 2023
10:47 CET
BERGENBIO BerGenBio ASA - Updated timeline for delivery of new shares 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
30 Nov 2023
17:30 CET
BERGENBIO BerGenBio ASA - Final results for the first exercise period for warrants issued in connection with rights issue 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
29 Nov 2023
19:00 CET
BERGENBIO BerGenBio ASA - Preliminary results for the first exercise period for warrants issued in connection with rights issue 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
28 Nov 2023
07:00 CET
BERGENBIO BerGenBio ASA - Last day of the first exercise period for warrants issued in connection with rights issue 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
28 Nov 2023
07:00 CET
BERGENBIO BerGenBio ASA - Siste dag av den første utøvelsesperioden for de frittstående tegningsrettene utstedt i forbindelse med fortrinnsrettsemisjonen 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
24 Nov 2023
13:46 CET
BERGENBIO BerGenBio ASA - Information about the first exercise period for warrants issued in connection with rights issue 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
21 Nov 2023
15:23 CET
BERGENBIO BerGenBio ASA Mandatory notification of trade by primary insiders and close associates 20103010 Biotechnology Mandatory notification of trade primary insiders
15 Nov 2023
07:00 CET
BERGENBIO BerGenBio ASA - Start av den første utøvelsesperioden for de frittstående tegningsrettene utstedt i forbindelse med fortrinnsrettsemisjonen 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
15 Nov 2023
07:00 CET
BERGENBIO BerGenBio ASA - Commencement of the first exercise period for warrants issued in connection with rights issue 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
14 Nov 2023
07:00 CET
BERGENBIO BerGenBio Reports Third Quarter 2023 Financial Results 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
13 Nov 2023
19:46 CET
BERGENBIO Financial calendar 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State